A supplement brand pharmacists can stand behind.

Both — but the formulations were specified with pharmacy-channel credibility as the primary constraint. Active-ingredient dosages map to evidence-based ranges; on-pack claims map to EU permitted claims; the brand voice avoids consumer-marketing language that fails pharmacist screening.

Yes. Stability data sheets per SKU are provided alongside CoA + TDS at qualification. Retained samples are held for shelf-life plus 12 months at the manufacturing site, accessible to qualified buyers for re-test if needed.

The manufacturing partner operates an adverse-event monitoring and reporting flow aligned with general EU food law (Regulation (EC) No 178/2002 — withdrawal and notification duties) and with national nutrivigilance schemes where they exist. Adverse-event history is available to qualified buyers on request — a clean track record over the operational window is part of the qualification dossier.

Yes, on a case-by-case basis. Once a pharmacy partner commits volume, N&T provides product-monographs, pharmacist-facing dosage guides, and counter-conversation prompts in the locales the chain serves. Format and depth are negotiated per buyer.

3-9 months in our experience — slower than importer/distributor cycles because pharmacy boards involve a pharmacist sign-off layer. We support extended evaluation periods and can ship qualifying samples to multiple sites for in-pharmacy trial before a full listing decision.